|
1
|
Beckett MK, Elliott MN, Clemens JQ, Ewing
B and Berry SH: Consequences of interstitial cystitis/bladder pain
symptoms on women's work participation and income: Results from a
national household sample. J Urol. 191:83–88. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yoshimura N, Homma Y, Tomoe H, Otsuka A,
Kitta T, Masumori N, Akiyama Y, Niimi A, Mitsui T, Nanri M, et al:
Efficacy and safety of intravesical instillation of KRP-116D (50%
dimethyl sulfoxide solution) for interstitial cystitis/bladder pain
syndrome in Japanese patients: A multicenter, randomized,
double-blind, placebo-controlled, clinical study. Int J Urol.
28:545–553. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sadahira T, Maruyama Y, Watanabe T, Sekito
T, Mitsui Y, Wada K, Araki M and Watanabe M: Medical uses for
phenol in the urinary tract: A possible forgotten treatment
(Review). Med Int. 1(13)2021.
|
|
4
|
Sekito T, Sadahira T, Watanabe T, Maruyama
Y, Watanabe T, Iwata T, Wada K, Edamura K, Araki M and Watanabe M:
Medical uses for silver nitrate in the urinary tract (Review).
World Acad Sci J. 4(6)2022.
|
|
5
|
Hunner GL: A rare type of bladder ulcer in
women; report of cases. Boston Med Surg J. 172:660–664. 1915.
|
|
6
|
Homma Y, Akiyama Y, Tomoe H, Furuta A,
Ueda T, Maeda D, Lin AT, Kuo HC, Lee MH, Oh SJ, et al: Clinical
guidelines for interstitial cystitis/bladder pain syndrome. Int J
Urol. 27:578–589. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Abrams P, Andersson KE, Apostolidis A,
Birder L, Bliss D, Brubaker L, Cardozo L, Castro-Diaz D, O'Connell
PR, Cottenden A, et al: 6th international consultation on
incontinence. Recommendations of the international scientific
committee: Evaluation and treatment of urinary incontinence, pelvic
organ prolapse and faecal incontinence. Neurourol Urodyn.
37:2271–2272. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Parsons CL, Lilly JD and Stein P:
Epithelial dysfunction in nonbacterial cystitis (interstitial
cystitis). J Urol. 145:732–735. 1991.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Evans AR, Nicol GD and Vasko MR:
Differential regulation of evoked peptide release by
voltage-sensitive calcium channels in rat sensory neurons. Brain
Res. 712:265–273. 1996.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Herzberg U, Eliav E, Dorsey JM, Gracely RH
and Kopin IJ: NGF involvement in pain induced by chronic
constriction injury of the rat sciatic nerve. Neuroreport.
8:1613–1618. 1997.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lamb K, Gebhart GF and Bielefeldt K:
Increased nerve growth factor expression triggers bladder
overactivity. J Pain. 5:150–156. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dmitrieva N and McMahon SB: Sensitisation
of visceral afferents by nerve growth factor in the adult rat.
Pain. 66:87–97. 1996.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Neblett R, Cohen H, Choi Y, Hartzell MM,
Williams M, Mayer TG and Gatchel RJ: The Central Sensitization
Inventory (CSI): Establishing clinically significant values for
identifying central sensitivity syndromes in an outpatient chronic
pain sample. J Pain. 14:438–445. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Walitt B, Nahin RL, Katz RS, Bergman MJ
and Wolfe F: The prevalence and characteristics of fibromyalgia in
the 2012 National Health Interview Survey. PLoS One.
10(e0138024)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Whitehead WE, Palsson O and Jones KR:
Systematic review of the comorbidity of irritable bowel syndrome
with other disorders: What are the causes and implications?
Gastroenterology. 122:1140–1156. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Oravisto KJ: Epidemiology of interstitial
cystitis. Ann Chir Gynaecol Fenn. 64:75–77. 1975.PubMed/NCBI
|
|
17
|
Leppilahti M, Sairanen J, Tammela TL,
Aaltomaa S, Lehtoranta K and Auvinen A: Prevalence of clinically
confirmed interstitial cystitis in women: A population based study
in Finland. J Urol. 174:581–583. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Berry SH, Elliott MN, Suttorp M, Bogart
LM, Stoto MA, Eggers P, Nyberg L and Clemens JQ: Prevalence of
symptoms of bladder pain syndrome/interstitial cystitis among adult
females in the United States. J Urol. 186:540–544. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Walker MC, Masters JR, Parris CN, Hepburn
PJ and English PJ: Intravesical chemotherapy: In vitro studies on
the relationship between dose and cytotoxicity. Urol Res.
14:137–140. 1986.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gordh T: Xylocain, a new local analgesic.
Anaesthesia. 4:4–9. 1949.PubMed/NCBI View Article : Google Scholar
|
|
21
|
MacGregor RR, Thorner RE and Wright DM:
Lidocaine inhibits granulocyte adherence and prevents granulocyte
delivery to inflammatory sites. Blood. 56:203–209. 1980.PubMed/NCBI
|
|
22
|
Seeman P: The membrane actions of
anesthetics and tranquilizers. Pharmacol Rev. 24:583–655.
1972.PubMed/NCBI
|
|
23
|
Su D, Gu Y, Wang Z and Wang X: Lidocaine
attenuates proinflammatory cytokine production induced by
extracellular adenosine triphosphate in cultured rat microglia.
Anesth Analg. 111:768–774. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Serra MF, Anjos-Valotta EA, Olsen PC,
Couto GC, Jurgilas PB, Cotias AC, Pão CR, Ferreira TP, Arantes AC,
Pires AL, et al: Nebulized lidocaine prevents airway inflammation,
peribronchial fibrosis, and mucus production in a murine model of
asthma. Anesthesiology. 117:580–591. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kissin I, Lee SS and Bradley EL Jr: Effect
of prolonged nerve block on inflammatory hyperalgesia in rats:
Prevention of late hyperalgesia. Anesthesiology. 88:224–232.
1998.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fenton BW, Palmieri PA and Fanning J:
Receiver operating characteristic curves of symptom scores in the
diagnosis of interstitial cystitis/painful bladder syndrome. J
Minim Invasive Gynecol. 15:601–604. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Butrick CW, Sanford D, Hou Q and Mahnken
JD: Chronic pelvic pain syndromes: Clinical, urodynamic, and
urothelial observations. Int Urogynecol J Pelvic Floor Dysfunct.
20:1047–1053. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Taneja R: Intravesical lignocaine in the
diagnosis of bladder pain syndrome. Int Urogynecol J. 21:321–324.
2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Offiah I, Dilloughery E, McMahon SB and
O'Reilly BA: Prospective comparative study of the effects of
lidocaine on urodynamic and sensory parameters in bladder pain
syndrome. Int Urogynecol J. 30:1293–1301. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Henry R, Patterson L, Avery N, Tanzola R,
Tod D, Hunter D, Nickel JC and Morales A: Absorption of alkalized
intravesical lidocaine in normal and inflamed bladders: A simple
method for improving bladder anesthesia. J Urol. 165:1900–1903.
2001.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nickel JC, Moldwin R, Lee S, Davis EL,
Henry RA and Wyllie MG: Intravesical alkalinized lidocaine (PSD597)
offers sustained relief from symptoms of interstitial cystitis and
painful bladder syndrome. BJU Int. 103:910–918. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Parsons CL: Successful downregulation of
bladder sensory nerves with combination of heparin and alkalinized
lidocaine in patients with interstitial cystitis. Urology.
65:45–48. 2005.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Parsons CL, Zupkas P, Proctor J, Koziol J,
Franklin A, Giesing D, Davis E, Lakin CM, Kahn BS and Garner WJ:
Alkalinized lidocaine and heparin provide immediate relief of pain
and urgency in patients with interstitial cystitis. J Sex Med.
9:207–212. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Welk BK and Teichman JM: Dyspareunia
response in patients with interstitial cystitis treated with
intravesical lidocaine, bicarbonate, and heparin. Urology.
71:67–70. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lv YS, Zhou HL, Mao HP, Gao R, Wang YD and
Xue XY: Intravesical hyaluronic acid and alkalinized lidocaine for
the treatment of severe painful bladder syndrome/interstitial
cystitis. Int Urogynecol J. 23:1715–1720. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nickel JC, Jain P, Shore N, Anderson J,
Giesing D, Lee H, Kim G, Daniel K, White S, Larrivee-Elkins C, et
al: Continuous intravesical lidocaine treatment for interstitial
cystitis/bladder pain syndrome: Safety and efficacy of a new drug
delivery device. Sci Transl Med. 4(143ra100)2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Evans R, Kohan A, Moldwin R, Radecki D,
Geib T and Peters KM: Safety, tolerability, and efficacy of LiRIS
400 mg in women with interstitial cystitis/bladder pain syndrome
with or without Hunner lesions. Neurourol Urodyn. 40:1730–1739.
2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chancellor MB: Future trends in the
treatment of urinary incontinence. Rev Urol. 3 (Suppl 1):S27–S34.
2001.PubMed/NCBI
|
|
39
|
Oxybutynin intravesical-situs. I-oxy.
Drugs R D. 3:82–83. 2002.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lee H and Cima MJ: An intravesical device
for the sustained delivery of lidocaine to the bladder. J Control
Release. 149:133–139. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Peters K, Seifu Y, Cutie C and Radecki D:
MP72-16 safety, tolerability, and preliminary efficacy of LiRIS 400
mg in women with ulcerative interstitial cystitis. J Urol.
195:e958. 2016.
|
|
42
|
Xu X, Goyanes A, Trenfield SJ, Diaz-Gomez
L, Alvarez-Lorenzo C, Gaisford S and Basit AW: Stereolithography
(SLA) 3D printing of a bladder device for intravesical drug
delivery. Mater Sci Eng C Mater Biol Appl.
120(111773)2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kim CR, Jang EB, Hong SH, Yoon YE, Huh BK,
Kim SN, Kim MJ, Moon HS and Choy YB: Indwelling urinary catheter
assembled with lidocaine-loaded polymeric strand for local
sustained alleviation of bladder discomfort. Bioeng Transl Med.
6(e10218)2021.PubMed/NCBI View Article : Google Scholar
|
